You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

FGFR4

Showing 26 - 50 of 268
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Integrated Molecular Profiling in Advanced Cancers Trial

Active, not recruiting
  • Breast Cancer
  • +9 more
    • Toronto, Ontario, Canada
      Princess Margaret Hospital
    Sep 26, 2022

    Gastric Cancer, Gastroesophageal Junction Adenocarcinoma Trial in Worldwide (Bemarituzumab, Nivolumab, mFOLFOX6)

    Recruiting
    • Gastric Cancer
    • Gastroesophageal Junction Adenocarcinoma
    • Phoenix, Arizona
    • +119 more
    Feb 1, 2023

    Advanced Cancer, Metastatic Cancer Trial in Canada, United States (LY3076226)

    Completed
    Has Results
    • Advanced Cancer
    • Metastatic Cancer
    • Philadelphia, Pennsylvania
    • +3 more
    Apr 9, 2020

    Cholangiocarcinoma, FGFR2 Fusion, FGFR2 Gene Mutation Trial in United States (TT-00420)

    Recruiting
    • Cholangiocarcinoma
    • +4 more
    • Anchorage, Alaska
    • +16 more
    Jan 3, 2023

    Urinary Bladder Tumors, Tumor Metastasis, Ureteral Tumors Trial in New York, Myrtle Beach, Nashville (LOXO-435, Pembrolizumab)

    Recruiting
    • Urinary Bladder Neoplasms
    • +2 more
    • New York, New York
    • +2 more
    Jan 31, 2023

    Solid Tumor, FGF Receptor Gene Mutation, FGF Amplification Trial in Tianjin (Pemigatinib)

    Recruiting
    • Solid Tumor
    • +4 more
    • Tianjin, Tianjin, China
      Tianjin Medical University Second Hospital
    Aug 28, 2023

    Squamous-cell NSCLC Trial in Switzerland (Rogaratinib)

    Active, not recruiting
    • Squamous-cell Non-small Cell Lung Cancer
    • Baden, Switzerland
    • +10 more
    Jan 20, 2022

    Advanced Cholangiocarcinoma, FGFR2 Fusions, Gene Rearrangement Trial (TAS-120)

    Not yet recruiting
    • Advanced Cholangiocarcinoma
    • +2 more
    • (no location specified)
    Feb 3, 2023

    Gastric Cancer, Gastroesophageal Junction Adenocarcinoma Trial in Worldwide (Bemarituzumab, mFOLFOX6, Placebo)

    Recruiting
    • Gastric Cancer
    • Gastroesophageal Junction Adenocarcinoma
    • Anchorage, Alaska
    • +140 more
    Aug 11, 2022

    Gastric Adenocarcinoma Trial in Worldwide (Derazantinib, Derazantinib-paclitaxel-ramucirumab, Derazantinib-atezolizumab)

    Completed
    • Gastric Adenocarcinoma
    • Orlando, Florida
    • +80 more
    Jan 13, 2023

    Upper Tract Urothelial Carcinomas, Urothelial Bladder Cancer Trial in Worldwide (Infigratinib, Placebo)

    Recruiting
    • Upper Tract Urothelial Carcinomas
    • Urothelial Bladder Cancer
    • Tucson, Arizona
    • +133 more
    Apr 25, 2022

    Solid Tumor, Adult, Intrahepatic Cholangiocarcinoma, Urothelial Carcinoma Trial in Taiwan, United States (KIN-3248)

    Recruiting
    • Solid Tumor, Adult
    • +2 more
    • La Jolla, California
    • +4 more
    Aug 9, 2022

    Advanced or Metastatic Solid Tumor, Advanced or Metastatic Gastric or Gastroesophageal Cancer, Myeloid or Lymphoid Tumors (MLN)

    Active, not recruiting
    • Advanced or Metastatic Solid Tumor
    • +2 more
    • Gilbert, Arizona
    • +60 more
    Oct 20, 2022

    Advanced and Metastatic Urothelial Cancer Trial in France, Spain, United States (futibatinib and pembrolizumab)

    Recruiting
    • Advanced and Metastatic Urothelial Cancer
    • futibatinib and pembrolizumab
    • San Francisco, California
    • +17 more
    Oct 25, 2022

    Gastrointestinal Cancer Trial in Tianjin (Pemigatinib)

    Recruiting
    • Gastrointestinal Cancer
    • Tianjin, Tianjin, China
      Tianjin Medical University Cancer Institute & Hospital
    Dec 7, 2022

    Leiomyosarcoma, Liposarcoma, Soft Tissue Sarcoma Adult Trial in Taipei (Eribulin, Lenvatinib)

    Active, not recruiting
    • Leiomyosarcoma
    • +3 more
    • Taipei, Taiwan
    • +1 more
    Dec 27, 2022

    Bladder Cancer Trial in Vandœuvre-lès-Nancy (Urine collection (150ml), Blood sample (20 ml))

    Recruiting
    • Bladder Cancer
    • Urine collection (150ml)
    • Blood sample (20 ml)
    • Vandœuvre-lès-Nancy, France
      Institut de Cancérologie de Lorraine
    Mar 23, 2022

    Advanced Solid Tumor Trial in Worldwide (Erdafitinib)

    Recruiting
    • Advanced Solid Tumor
    • Tucson, Arizona
    • +199 more
    Jan 27, 2023

    Advanced Intrahepatic Cholangiocarcinoma Trial (Pemigatinib)

    Not yet recruiting
    • Advanced Intrahepatic Cholangiocarcinoma
    • (no location specified)
    Sep 30, 2022

    Bladder Cancer Trial in Indianapolis, Baltimore, Rockledge (Dovitinib)

    Terminated
    Has Results
    • Bladder Cancer
    • Indianapolis, Indiana
    • +2 more
    Jul 7, 2022

    Advanced or Metastatic Solid Tumor Trial in Worldwide (Rogaratinib (BAY1163877), Copanlisib (BAY80-6946))

    Completed
    • Advanced or Metastatic Solid Tumor
    • Rogaratinib (BAY1163877)
    • Copanlisib (BAY80-6946)
    • Los Angeles, California
    • +19 more
    Jul 13, 2022

    FGFR Gene Mutations in Tumor Tissue and Urine of Urothelial

    Not yet recruiting
    • Bladder Cancer
    • FGFR test
    • (no location specified)
    Apr 6, 2022

    Urothelial Carcinoma Trial in Worldwide (Derazantinib dose level 1 (300mg once daily) monotherapy, Derazantinib various dose

    Completed
    • Urothelial Carcinoma
    • Derazantinib dose level 1 (300mg once daily) monotherapy
    • +4 more
    • Newnan, Georgia
    • +65 more
    Oct 19, 2022

    Urinary Bladder Tumors, Receptors, Fibroblast Growth Factor Trial in Japan (Erdafitinib Intravesical Delivery System)

    Not yet recruiting
    • Urinary Bladder Neoplasms
    • Receptors, Fibroblast Growth Factor
    • Erdafitinib Intravesical Delivery System
    • Kanagawa, Japan
    • +3 more
    Jan 27, 2023

    Bladder Carcinoma, Bladder Urothelial Carcinoma, Muscle Invasive Bladder Carcinoma Trial in Toronto (biological, procedure,

    Recruiting
    • Bladder Carcinoma
    • +7 more
    • Atezolizumab
    • +5 more
    • Toronto, Ontario, Canada
      University Health Network Princess Margaret Cancer Center LAO
    Nov 8, 2022